Editorial: tenofovir disoproxil fumarate vs entecavir in patients with chronic hepatitis B and renal impairment—still an open issue

Sung Won Lee; Seung Up Kim

doi:10.1111/apt.15965

Editorial: tenofovir disoproxil fumarate vs entecavir in patients with chronic hepatitis B and renal impairment—still an open issue

Sung Won Lee, Seung Up Kim

Department of Internal Medicine

Research output: Contribution to journal › Editorial › peer-review

1 Citation (Scopus)

Original language	English
Pages (from-to)	889-890
Number of pages	2
Journal	Alimentary Pharmacology and Therapeutics
Volume	52
Issue number	5
DOIs	https://doi.org/10.1111/apt.15965
Publication status	Published - 2020 Sept 1

Bibliographical note

Funding Information:
Declaration of personal interests: Sung Won Lee has served as a speaker, a consultant and an advisory board member for Abbvie pharmaceuticals, Gilead Sciences, Eisai Co., Ltd, MSD Corp., BMS pharmaceuticals.

All Science Journal Classification (ASJC) codes

Hepatology
Gastroenterology
Pharmacology (medical)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/apt.15965

Cite this

@article{b0e4cd34c2954128944651f76ed78741,

title = "Editorial: tenofovir disoproxil fumarate vs entecavir in patients with chronic hepatitis B and renal impairment—still an open issue",

author = "Lee, {Sung Won} and Kim, {Seung Up}",

note = "Funding Information: Declaration of personal interests: Sung Won Lee has served as a speaker, a consultant and an advisory board member for Abbvie pharmaceuticals, Gilead Sciences, Eisai Co., Ltd, MSD Corp., BMS pharmaceuticals.",

year = "2020",

month = sep,

day = "1",

doi = "10.1111/apt.15965",

language = "English",

volume = "52",

pages = "889--890",

journal = "Alimentary Pharmacology and Therapeutics",

issn = "0269-2813",

publisher = "Wiley-Blackwell",

number = "5",

}

TY - JOUR

T1 - Editorial

T2 - tenofovir disoproxil fumarate vs entecavir in patients with chronic hepatitis B and renal impairment—still an open issue

AU - Lee, Sung Won

AU - Kim, Seung Up

N1 - Funding Information: Declaration of personal interests: Sung Won Lee has served as a speaker, a consultant and an advisory board member for Abbvie pharmaceuticals, Gilead Sciences, Eisai Co., Ltd, MSD Corp., BMS pharmaceuticals.

PY - 2020/9/1

Y1 - 2020/9/1

UR - http://www.scopus.com/inward/record.url?scp=85089422607&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85089422607&partnerID=8YFLogxK

U2 - 10.1111/apt.15965

DO - 10.1111/apt.15965

M3 - Editorial

C2 - 32852818

AN - SCOPUS:85089422607

SN - 0269-2813

VL - 52

SP - 889

EP - 890

JO - Alimentary Pharmacology and Therapeutics

JF - Alimentary Pharmacology and Therapeutics

IS - 5

ER -

Editorial: tenofovir disoproxil fumarate vs entecavir in patients with chronic hepatitis B and renal impairment—still an open issue

Bibliographical note

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Cite this